HONG KONG, Nov. 7, 2013 /PRNewswire-FirstCall/ -- China Cord
Blood Corporation (NYSE: CO) (the "Company") today announced its
plan to release financial results for the second quarter and first
half of fiscal year 2014 on Thursday,
November 14, 2013, after market close in the US.
The Company will host a conference call at 8:00 a.m. ET on Friday,
November 15, 2013 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties
may access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the conference call and available for
three weeks at the same URL link above. Listeners may also
access the call by dialing 1-631-514-2526 or 1-855-298-3404 for US
callers or +852-5808-3202 for Hong
Kong callers, access code: 5266601.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the second quarter of fiscal 2014 earnings press release
will be available at http://www.chinacordbloodcorp.com, in the
section titled Investor Center/Press Release, after 4:00 p.m. ET on Thursday,
November 14, 2013 and in the Company's Report on Form 6-K
for the month of November 2013
available on the Securities and Exchange Commission's website at
www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses.
Under current PRC government regulations, only one licensed cord
blood banking operator is permitted to operate in each licensed
region and only seven licenses have been authorized as of today.
China Cord Blood Corporation provides cord blood collection,
laboratory testing, hematopoietic stem cell processing and stem
cell storage services. For more information, please visit the
Company's website at
http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
SOURCE China Cord Blood Corporation